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Abstract 
Nonribosomal peptide synthetases (NRPSs) are large multimodular and multidomain 
enzymes that are involved in synthesising an array of molecules that are important in 
human and animal health. NRPSs are found in both bacteria and fungi but most of the 
research to date has focused on the bacterial enzymes. This is largely due to the technical 
challenges in producing active fungal NRPSs, which stem from their large size and 
multidomain nature. In order to target fungal NRPS domains for biochemical and 
structural characterisation, we tackled this challenge by using the cloning and expression 
tools of structural genomics to screen the many variables that can influence the 
expression and purification of proteins. Using these tools we have screened 32 constructs 
containing 16 different fungal NRPS domains or domain combinations for expression and 
solubility. Two of these yielded soluble protein with one, the third adenylation domain of 
the SidN NRPS (SidNA3) from the grass endophyte Neotyphodium lolii, being tractable 
for purification using Ni-affinity resin. The initial purified protein exhibited poor solution 
behaviour but optimisation of the expression construct and the buffer conditions used for 
purification, resulted in stable recombinant protein suitable for biochemical 
characterisation, crystallisation and structure determination. 
 
Keywords: protein screening, protein expression, nonribosomal peptide synthetases, 
fungi, natural products, siderophore 
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Introduction 
Nonribosomal peptide synthetases (NRPSs)1 make up an important class of biosynthetic 
enzymes that are involved in the production of a large array of short peptides, including 
many molecules that are used in the context of human and animal health [1]. To date, 
NRPSs have only been confirmed to be present in bacteria and fungi [2], although 
putative gene products with NRPS-like signatures have been identified in Oryza sativa 
and Caenorhabditis elegans [3]. NRPSs synthesise peptides by a multiple carrier 
thiotemplate mechanism [4, 5]. They are large, multimodular enzymes with each module 
catalysing the incorporation of one subunit into the peptide being synthesised. NRPS 
modules are, in turn, made up of independently-folding functional domains that catalyse 
the individual reactions of peptide synthesis. Three domains make up the minimum 
elongation module, the adenylation (A), peptidyl carrier protein (PCP) and condensation 
(C) domains. In addition to these core domains, there are a number of auxiliary domains, 
such as N-methylation (Met) and reduction (R) domains, that sometimes make up part of 
modules and chemically modify the peptide as it is being synthesised. 
 
Despite the fact that many of the important products of NRPSs are from fungi, most 
NRPS research to date has focused on enzymes of bacterial origin due to the technical 
difficulty of producing active fungal NRPS enzymes [6]. The most significant technical 
challenge in producing fungal NRPS proteins is the very large size of these enzymes. For 
example the peptaibol synthetase from Trichoderma virens is made up of 20,925 amino 
acid residues [7]. To mitigate this problem, research efforts have often focused on 
individual domains or combinations of small groups of domains. In bacteria, this is 
assisted by the fact that separate genes often encode individual domains. In fungi 
however, NRPS enzymes are usually encoded by a single large gene, which is translated 
into a multimodular, multidomain protein. This often necessitates the expression of 
individual domains (from the larger multidomain protein), which is a process that is 
fraught with difficulties [8, 9]. Hence, it is not surprising that there are few examples of 
the successful production of active fungal NRPS enzymes using heterologous expression 
systems [10] and the subsequent biochemical characterisation of these enzymes. 
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One potential strategy to tackle this technical challenge is to make use of the high-
throughput cloning and expression screening systems [11, 12] that have been developed 
for structural genomics programs over the past decade. In the context of structural 
genomics, the high-throughput tools are used to screen large numbers of genes for the 
production of soluble proteins that can then be screened for crystal growth and structure 
determination. However, this approach can also be used to rapidly screen large numbers 
of constructs from targeted genes to find conditions under which domains can be stably 
and solubly expressed and purified. This can also facilitate the expression and 
purification of challenging proteins or protein classes by screening many other variables 
that can influence the expression and purification of proteins such as expression 
temperature and cell-lysis conditions [12].  
 
A large number of uncharacterised NRPSs have recently been identified in the 
Epichloë/Neotyphodium complex (phylum Ascomycota, family Clavicipitaceae) of 
endophytic fungi [13]. The mutualistic relationship between the endophytes and the 
agronomic grasses that they colonise plays a vital role in pastoral agriculture by 
improving the grass plants’ tolerance to biotic and abiotic stresses [14, 15]. The 
production of large amounts of soluble protein of domains from endophyte NRPSs would 
greatly facilitate their characterisation. In particular, the structural analysis of endophyte 
adenylation (A) domains will be of significant value in improving the substrate 
specificity prediction methods that currently work well for bacterial A domains but 
usually fail for A domains of fungal origin [6]. By using a cloning and expression 
screening system originally developed for structural genomics [16], we have successfully 
developed an expression construct and purification protocol that allows the production of 
pure, stable recombinant protein for an endophyte A domain. This, in turn has provided 
the basis for the first structural elucidation of a eukaryotic NRPS A domain [17].  
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Materials and Methods 
Definition of domain borders of NRPS constructs 
Domain border definition was accomplished by the generation of multiple sequence 
alignments using ClustalW via the ClustalX interface [18]. Known secondary structure 
elements (if available) were used to set gap penalties for ClustalW alignments. The 
locations of the domains were approximately estimated and the sequences for each 
domain were aligned with those from a number of previously published NRPS sequences 
from fungi and bacteria. The domain boundaries were defined from these alignments 
based on previously determined structures of bacterial A [19], C [20], and PCP [21] 
domains. Although no structures for NRPS Met and R domains were available, the 
boundaries of these domains could be defined based on the adjacent domains (the A 
domain into which the Met domain is inserted and the PCP domain preceding the R 
domain). 
 
Gateway cloning  
Cloning was carried out using the Gateway cloning system (Invitrogen) as described 
previously [16]. The NRPS fragments from four NRPS genes were amplified via PCR 
from N. lolii Lp19 genomic DNA. A two-step nested PCR reaction was used to introduce 
the sequence encoding the recombinant Tobacco Etch Virus (rTEV) protease cleavage 
site into the PCR product which would allow the N-terminal affinity tags to be cleaved 
from the expressed protein. The PCR primers used are shown in Table S1 and Table S2. 
A BP reaction using the BP clonase enzyme (Invitrogen) was performed to recombine the 
amplified fragments into the pDONR221 plasmid. The correct clones were identified by 
restriction enzyme analysis and verified by sequencing. The fragments were then 
recombined into the pDEST15 and pDEST17 expression vectors via a LR reaction using 
the LR clonase enzyme (Invitrogen). As the cloned fragments contain rare codons, the 
resulting expression constructs were transformed into E. coli Rosetta (DE3) for 
expression. This expression strain habours a plasmid that encodes the rare tRNA genes 
for Arg, Ile, Gly, Leu, Pro, Met, Thr and Tyr tRNAs.  
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Expression testing 
Expression testing was performed in 96-well format as described previously [16]. The 
expression cultures were grown in 1 mL of autoinduction medium [22] containing 
ampicillin (100 µg/mL) and chloramphenicol (25 µg/mL) in each well of a 96-well deep-
well plate. Six replicates each of sixteen expression constructs can conveniently be 
processed at once. The cultures were incubated with shaking at 800 rpm on a 
Thermomixer Comfort (Eppendorf) that allows expression to be performed at various 
temperatures. The cultures were grown at 37 °C for 3 h 30 min and the temperature was 
then set to the desired expression temperature. The culture was grown at the desired 
expression temperature for 13 h to 16 h for 37 °C expression, 15 h to 18 h for 28 °C 
expression, and 24 h to 26 h for 18 °C and 10 °C expression. The cells were harvested by 
centifugation (1800 × g for 30 min) and resuspended in various lysis buffers. Lysozyme 
(1 mg/mL) and DNase I (10 µg/mL) were added, the cell suspension was incubated on 
ice for 30 min and MgCl2 (1 mM) was added. The cell suspensions were sonicated on ice 
using an eight-element probe for 4-5 15 s bursts at 80 W using a Vibra-Cell ultrasonic 
processor (Sonics). The lysed cell suspensions were transferred to a 96-well PCR plate 
and the plate centrifuged at 3,600 × g for 1 h at 4 °C to separate the soluble and insoluble 
fractions for analysis by SDS-PAGE. 
 
Small-scale affinity tag binding tests 
Cultures were grown in autoinduction medium [22] containing ampicillin (100 µg/mL) 
and chloramphenicol (25 µg/mL). Expression temperatures of 10 °C and 18 °C were used 
for the Nrps5Av1 and SidNA3 proteins, respectively. The lysis buffers contained 10 mM 
imidazole and after centrifugation to separate the soluble and insoluble fractions, 30 µL 
of Profinity IMAC Ni-charged resin (Bio-Rad) was added to the soluble fraction. The 
mixture was incubated on ice for 1 h with periodic mixing. The sample was centrifuged at 
16,000 × g for 1 min at 4 °C. The supernatant was discarded and the resin washed by 
resuspending the resin in 600 µL of lysis buffer, centrifuging the sample at 16,000 × g for 
1 min at 4 °C, and discarding the supernatant. This washing cycle was repeated two more 
times and the samples analysed by SDS-PAGE. 
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Large-scale expression and purification of the SidNA3 domain 
The expression culture was grown in 500 mL of autoinduction medium [22] containing 
ampicillin (100 µg/mL) and chloramphenicol (25 µg/mL) at 37 °C for 3 h 30 min with 
shaking at 200 rpm. The culture was cooled to 18 °C and grown for 24 h to 26 h at this 
expression temperature. The cells were harvested by centrifugation (at 3000 × g for 
30 min at 4 °C) and resuspended in 6 mL of lysis buffer (25 mM sodium phosphate 
pH 6.5 or pH 8.0, 500 mM NaCl, 5 mM β-mercaptoethanol). Lysozyme (1 mg/mL), 
DNase I (10  µg/mL), and a Complete Mini EDTA-free (Roche) tablet were added. The 
cell suspension was incubated on ice for 30 min and MgCl2 (1 mM) was added. The cells 
were lysed by high-pressure cell disruption at 18.5 kPa using a One Shot cell disruptor 
(ConstantSystems Ltd.). The lysed cell suspension was transferred to a SS-34 tube and 
centrifuged at 20,000 × g for 30 min at 4 °C.  
 
The first step of the purification of the SidNA3 protein was via immobilised metal 
affinity chromatography (IMAC). The supernatant was loaded onto a 5 mL HiTrap 
Chelating HP column (GE Healthcare) loaded with Ni2+ ions and pre-equilibrated with 
lysis buffer. The column was washed with 15 ml to 30 mL lysis buffer containing 10 mM 
imidazole. The bound proteins were eluted from the column by running a gradient from 
10 mM to 500 mM imidazole over 50 mL. The fractions containing the SidNA3 protein 
were pooled and dialysed against lysis buffer at 4 °C overnight to remove the imidazole. 
The rTEV protease (recombinant Tobacco Etch Virus NIa protease modified to contain a 
poly-Histidine tag) was used to cleave the poly-Histidine tag from the SidNA3 protein. 
The protein sample was supplemented with 0.1 mM EDTA and the rTEV protease added 
in an approximate rTEV to SidNA3 ratio of 1:20 (w/w). The mixture was incubated 
overnight at room temperature.  
 
Subtractive IMAC was performed to separate the rTEV, cleaved poly-Histidine tags, and 
undigested SidNA3 protein from the digested SidNA3 protein. The protein solution was 
loaded onto a 5 mL HiTrap Chelating HP column (GE Healthcare) loaded with Ni2+ ions 
and pre-equilibrated with lysis buffer. The column was washed with 30 mL lysis buffer 
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containing 10 mM imidazole. The flow-though and wash (containing the SidNA3 
protein) were pooled and concentrated using a 20 mL Vivaspin concentrator (Sartorius 
AG) with a molecular weight cut off of 30 kDa to a volume of ~0.5 mL. 
 
SEC was used to further purify proteins that had been purified by IMAC and also to 
remove large soluble aggregates of the target protein. The concentrated protein solution 
was loaded onto a HiLoad 16/60 Superdex 200 pg column (GE Healthcare) column pre-
equilibrated with running buffer (25 mM HEPES pH 7.5, 150 mM NaCl, 5 mM 
β-mercaptoethanol or 25 mM MES pH 6.5, 500 mM NaCl, 5 mM β-mercaptoethanol) 
and eluted with one column volume (120 mL) of running buffer at a flow rate of 
1 mL/min. 
 
Dynamic light scattering measurements and screening of buffer conditions 
Dynamic light scattering (DLS) was used to analyse the state of aggregation and 
polydispersity of protein samples [23]. Protein samples were centrifuged at 16,000 × g 
for 10 min at 4 °C, 12 µL to 15 µL was placed into a clean, dry quartz cuvette and DLS 
analysis performed on a DynaPro MTSC Dynamic Light Scattering Instrument (Protein 
Solutions Inc.).  
 
For screening of buffer conditions via DLS, protein solutions from the fractions collected 
from the monomer peak of the SEC run were immediately diluted into a series of buffers 
with a range of pH values (pH 5.5, pH 6.5, pH 7.5 and pH 9.0) and salt concentrations 
(150 mM NaCl and 500 mM NaCl). The diluted protein solutions were analysed via DLS.  
The protein solutions were concentrated to ~1.5 mg/mL using 600 µL Vivaspin 
concentrators (Sartorius AG) with molecular weight cut offs of 30 kDa and DLS analysis 
was performed on them again, and a third time after storage at 4 °C for 2 days.  
  
 9
Results and Discussion 
We screened a range of constructs of fungal NRPS domains. The boundaries of the 
domains were estimated based on multiple sequence alignments and comparison to 
previously published structures of the three core NRPS domains from bacterial enzymes 
[19-21]. Gateway cloning was used to screen sixteen different domains and domain 
combinations from four endophyte NRPSs. The four NRPSs were PerA, a recently 
discovered NRPS which synthesises the insect-feeding deterrent peramine [24]; LpsA, a 
three-module NRPS which is involved in the biosynthesis of the toxic ergopeptine 
alkaloid, ergovaline [25, 26]; Nrps5, a novel single-module NRPS with an unknown 
product [13]; and SidN, a three-module NRPS which is involved in the synthesis of an 
extracellular siderophore that is essential for the maintenance of the mutualistic character 
of the grass-endophyte relationship (Linda Johnson, unpublished results). At the time that 
the domains were cloned, only a fragment of the SidN NRPS gene, encompassing the 
second and third modules of this NRPS, had been sequenced. Hence, only the SidN 
domains that were encoded by this DNA fragment were included. The domains and 
amino acids included in each fragment are detailed in Table 1. These constructs were 
cloned from N. lolii Lp19 genomic DNA using the Gateway cloning system and the 
pDEST17 and pDEST15 vectors which also incorporate cleavable poly-Histidine and 
GST tags respectively. The Gateway cloning system results in additional amino acid 
residues between the fusion tag and target protein due to the required recombination 
sequences that flank the target sequence. Although, these extra residues have the potential 
to affect the solubility of the expressed proteins [16], we find that the convenience of this 
cloning system outweighs this possible downside. To mitigate against these extra residues 
causing ongoing problems during biochemical characterisation, our approach uses nested 
PCR to introduce an rTEV protease cleavage site between the N-terminus of the protein 
and the Gateway recombination site. This results in just three extra amino acids at the N-
terminus of the protein following cleavage with rTEV protease.   
 
Expression testing using a range of lysis buffers and at a range of temperatures showed 
that protein was expressed from all of the constructs (Table 2). Following lysis, soluble 
protein was produced for two of the constructs (Table 2; Fig. 1A, B), SidNA3 (the third 
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adenylation domain from the three-module SidN NRPS) and Nrps5Av1 (the adenylation 
domain from the one-module Nrps5 NRPS and an extra 232 residues at the N-terminus 
with no homology to any characterised NRPS domain). Low expression temperatures, 
with a maximum of 18 °C for SidNA3 and 10 °C for Nrps5Av1, were required in order 
for the proteins to be expressed in soluble form. A general increase in the production of 
soluble protein by expression at low temperatures has been widely observed [11], and 
although the reasons for this increase remain unclear, it is likely to be due to the kinetics 
of protein folding in E. coli and the upregulation of chaperones at these temperatures.  
 
Both the poly-Histidine tagged and GST tagged SidNA3 proteins were soluble but only 
the poly-Histidine tagged version of the Nrps5Av1 was soluble. To check whether the 
soluble poly-Histidine tagged SidNA3 and Nrps5Av1 proteins were tractable for 
purification, small-scale affinity tag binding tests were conducted on cultures expressed 
at 18 °C and 10 °C, respectively. The SidNA3 protein bound to the affinity resin but the 
Nrps5Av1 protein did not. Repeating the small-scale affinity tag binding tests using a set 
of different lysis buffers did not result in binding of the Nrps5Av1 protein to the resin. 
One possible reason why the soluble Nrps5Av1 protein does not bind to Ni-affinity resin 
is that the N-terminal poly-Histidine tag is buried in, or otherwise obscured by, the 
structure of the protein and is therefore inaccessible for binding. The additional 232 
residues at the N-terminus of the Nrps5Av1, which presumably form a domain of 
unknown function and structure, may be occluding the short poly-Histidine tag or causing 
aggregation. Although further work on the Nrps5Av1 protein (such as cloning it into a C-
terminal poly-Histidine tag expression vector) may allow it to be purified, we chose to 
focus on the SidNA3 protein, as it appeared to be more tractable.  
 
Large-scale expression of the poly-Histidine tagged SidNA3 protein was carried out at 
18 °C and the protein was purified via immobilised metal affinity chromatography 
(IMAC). Following dialysis to remove imidazole, the purified SidNA3 protein was 
digested with the rTEV protease to remove the poly-Histidine tag. Subtractive IMAC was 
carried out to remove the cleaved poly-Histidine tag, undigested SidNA3 protein and 
rTEV, although removal of the undigested SidNA3 protein was incomplete. To improve 
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the purity of the final protein sample, size exclusion chromatography (SEC) using a 16/60 
S200 column was performed using 25 mM HEPES pH 7.5 buffer with 150 mM NaCl and 
5 mM β-mercaptoethanol. There were two peaks on the 280 nm absorbance trace from 
SEC (Fig. 2A). The first peak was in the void volume of the column and consisted of 
protein aggregates (>600 kDa) containing the digested and undigested SidNA3 protein, 
while the second peak had a retention volume of ~70 mL and consisted of the monomeric 
digested SidNA3 protein (62.6 kDa; Fig. 2B). When the fractions under the monomeric 
peak were pooled and SEC repeated, the same two peaks with a similar peak size ratio 
were observed, showing that the SidNA3 protein was continuing to aggregate. Dynamic 
light scattering (DLS) analysis of fractions from under the monomeric peak confirmed 
that the SidNA3 protein was aggregating in solution, with molecular weight estimates of 
>1000 kDa and multimodal size distributions. In addition, the protein also precipitated 
slowly on storage at 4 °C.  
 
Aggregation and precipitation are detrimental for biochemical characterisation and 
crystallisation so efforts were made to improve the solution behaviour of the protein. One 
potential cause for the aggregation was incorrect identification of the domain boundaries. 
The presence or absence of even a few residues can have a profound impact on protein 
folding and stability when individual domains from a multidomain protein are expressed 
separately [8, 9]. In particular, if the constructs are too large, unstructured stretches at N- 
or C-terminus may lead to aggregation of the protein. Hence, two shorter constructs of 
SidNA3 were cloned using the Gateway system. The first, SidNA3v2 (residue range: 
2270-2826), had 14 residues removed from the N-terminus compared to the original 
fragment (residue range: 2256-2826), while the second, SidNA3v3 (residue range: 2270-
2811), had a further 15 residues removed from the C-terminus. The use of protein 
disorder prediction servers such as DISOPRED2 [27] can be helpful in predicting 
whether regions of protein are likely to be disordered. In the case of SidNA3, the 14 N-
terminal residues that were removed from the expression construct were not predicted to 
be disordered while the 15 residues removed from the C-terminus were predicted to be 
disordered. Expression testing showed that soluble protein was produced from both of the 
shorter constructs (data not shown).  
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Large-scale expression and purification of the poly-Histidine tagged SidNA3v2 and 
SidNA3v3 proteins was carried out as for the original SidNA3 protein. In both cases the 
SEC results showed a large reduction in the proportion of the protein that was aggregated 
when compared to the original SidNA3 construct (Fig. 3A, B). DLS measurements of 
fractions from under the monomeric peak showed that only a small amount of 
aggregation was occurring with typical average molecular weight estimates of about 
100 kDa (the expected molecular weights are 61.1 kDa and 59.4 kDa) and polydispersity 
indices (Cp/Rh) of about 28%. However, when the SidNA3v2 and SidNA3v3 protein 
solutions were concentrated, rapid aggregation was observed via DLS (molecular weight 
estimates of >1000 kDa). DLS was then used to screen a set of buffers with a range of pH 
values and NaCl concentrations. It was found that a pH of 6.5 and a NaCl concentration 
of 500 mM greatly reduced the aggregation of the protein when concentrated and large 
scale purification by SEC using 25 mM MES pH 6.5 buffer containing 500 mM NaCl and 
5 mM β-mercaptoethanol confirmed this (Fig. 4A, B). Protein from fractions under the 
peaks containing monomeric protein produced excellent DLS results with typical average 
molecular weight estimates of about 65 kDa and polydispersity indices (Cp/Rh) of 
between 7% and 15% (indicating a largely monodisperse protein solution). Concentration 
of the protein up to as much as 15 mg/mL did not result in any detectable aggregation, 
although over a period of several hours slow aggregation was evident by DLS analysis. 
The SidNA3v3 protein did, however, show a tendency to precipitate when concentrated. 
Thus, SidNA3v2 protein was selected for further experiments. SidNA3v2 has been 
shown to be active and the structure of the domain has been solved by X-ray 
crystallography; the biochemical characterisation and structure solution is described in 
detail elsewhere [17].  
 
Conclusions 
In summary, using a cloning and expression screening system originally developed for a 
structural genomics effort [16], we have successfully identified an expression construct 
and a purification protocol to produce large amounts of a soluble, stable recombinant 
fungal NRPS A domain - SidNA3 from the grass endophyte N. lolii. This is one of the 
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few examples of success in expressing and purifying active fungal NRPS enzymes [10]. 
We screened 16 NRPS domains or domain combinations for expression and solubility. 
These were cloned into two protein expression vectors (using Gateway-based 
approaches) giving a total of 32 constructs. These 32 constructs were screened at 
different expression temperatures and under different cell-lysis conditions yielding two 
different soluble domains. Of these two, one was tractable for purification using Ni-
affinity resin, named SidNA3, the third adenylation domain from SidN. However, the 
initial SidNA3 domain, when purified, exhibited poor solution behaviour, which was 
unsuitable for structure determination or biochemical characterisation. Optimisation of 
the SidNA3 expression construct, together with optimisation of the buffer conditions used 
for purification, resulted in SidNA3 protein that was stable in solution and suitable for 
both crystallisation and biochemical analysis. This success demonstrates the utility of 
high-throughput tools, originally developed for structural genomics, in tackling 
expression and solubility problems for challenging proteins. These tools can be used for 
both the initial screening of potential targets and optimising problematic expression and 
purification of particular proteins. Greater use of these tools has the potential to 
accelerate research efforts in cases where the production of the desired protein is a 
limiting factor. 
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Figure Legends 
Fig. 1. Expression of soluble protein from the SidNA3 and Nrps5Av1 constructs. SDS-
PAGE of the soluble fractions from expression tests of the poly-Histidine tagged (A) 
SidNA3 and (B) Nrps5Av1 proteins. The expression tests were conducted at 18 °C for 
the SidNA3 protein and 10 °C for the Nrps5Av1 protein. A negative control was run on 
each gel and for the SidNA3 protein a sample of a culture that was not induced was also 
run. The pH and the NaCl concentration in each of the lysis buffers are indicated. For the 
SidNA3 protein one sample was lysed in buffer containing 0.2% n-dodecyl-β-D-
maltoside (DDM). The expressed protein is marked with arrows. The gels were stained 
with Coomassie Blue and key protein standard sizes (kDa) are indicated.  
 
Fig. 2. Size exclusion chromatography of the SidNA3 protein using a 16/60 S200 
column. (A) The 280 nm absorbance trace from size exclusion purification of the SidNA3 
protein. The fractions collected are marked and numbered. (B) SDS-PAGE of the 
fractions from the SEC run. The combined fractions (Final) and sample that was loaded 
onto the column (Load) have also been run on the gel. The gels were stained with 
Coomassie Blue and key protein standard sizes (kDa) are indicated. 
 
Fig. 3. Size exclusion chromatography of the SidNA3v2 and SidNA3v3 proteins using a 
16/60 S200 column and pH 7.5 buffer containing 150 mM NaCl. The 280 nm absorbance 
traces from the SEC of the (A) SidNA3v2 and (B) SidNA3v3 proteins are shown. 
 
Fig. 4. Size exclusion chromatography of the SidNA3v2 and SidNA3v3 proteins using a 
16/60 S200 column and pH 6.5 buffer containing 500 mM NaCl. The 280 nm absorbance 
traces from the SEC of the (A) SidNA3v2 and (B) SidNA3v3 proteins are shown.  
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Tables 
 
 
Table 1 
Details of the NRPS fragments cloned using Gateway cloning. 
Construct Gene NRPS product Domains included Residue range included 
PerA1P perA Peramine A domain 1, PCP domain 1 262-911 
LpsA1 lpsA Ergovaline A domain 1 297-876 
LpsA1P lpsA Ergovaline A domain 1, PCP domain 1 297-958 
LpsA2 lpsA Ergovaline A domain 2 1257-1846 
LpsA2P lpsA Ergovaline A domain 2, PCP domain 2 1257-1932 
LpsA3 lpsA Ergovaline A domain 3 2368-2936 
LpsA3P lpsA Ergovaline A domain 3, PCP domain 3 2368-3021 
Nrps5Av1 nrps5 Unknown Unknown domaina, A domain 1-790 
Nrps5Av2 nrps5 Unknown A domain 233-790 
SidNPC2 sidN Siderophore PCP domain 2, C domain 2 1710-2268 
SidNC2 sidN Siderophore C domain 2 1814-2268 
SidNA3 sidN Siderophore A domain 3 2256-2826 
SidNA3P sidN Siderophore A domain 3, PCP domain 3 2256-2912 
SidNPC3 sidN Siderophore PCP domain 3, C domain 3 2822-3375 
SidNC3 sidN Siderophore C domain 3 2947-3375 
SidNC3P sidN Siderophore C domain 3, PCP domain 4 2947-3473 
aThe Nrps5 NRPS has and additional 232 residues at the N-terminus that do not show homology any 
characterised NRPS domain. 
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Table 2 
Results of testing the expression constructs made using Gateway cloning. 
pDEST17 (poly-Histidine tag) pDEST15 (GST tag) 
Construct 
Expressed Solublea Expressed Solublea 
PerA1P Yes No Yes No 
LpsA1 Yes No Yes No 
LpsA1P Yes No Yes No 
LpsA2 Yes No Yes No 
LpsA2P Yes No Yes No 
LpsA3 Yes No Yes No 
LpsA3P Yes No Yes No 
Nrps5Av1 Yes Yes (10 ºC) Yes No 
Nrps5Av2 Yes No Yes No 
SidNPC2 Yes No Yes No 
SidNC2 Yes No Yes No 
SidNA3 Yes Yes (18 ºC) Yes Yes (18 ºC) 
SidNA3P Yes No Yes No 
SidNPC3 Yes No Yes No 
SidNC3 Yes No Yes No 
SidNC3P Yes No Yes No 
aThe maximum expression temperature at which the protein is soluble is in brackets. 
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